[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":21926000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-240000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":199000.0,"OtherAssetsNoncurrent_0_Q3_USD":3306000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1284000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.055,"OperatingLeasesRentExpenseNet_3_Q3_USD":1500000.0,"OperatingLeasesRentExpenseNet_1_Q3_USD":500000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5989000.0,"OperatingLeasePayments_3_Q3_USD":1500000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":5103000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2250000.0,"OperatingLeaseLiability_0_Q3_USD":7353000.0,"OperatingExpenses_3_Q3_USD":98220000.0,"OperatingExpenses_1_Q3_USD":33677000.0,"NonoperatingIncomeExpense_3_Q3_USD":497000.0,"NonoperatingIncomeExpense_1_Q3_USD":311000.0,"NetIncomeLoss_3_Q3_USD":-97723000.0,"NetIncomeLoss_1_Q3_USD":-33366000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-81185000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-200896000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-4229000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":356000.0,"LiabilitiesCurrent_0_Q3_USD":21926000.0,"PaidInKindInterest_3_Q3_USD":399000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":429320000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2258000.0,"StockholdersEquity_0_Q3_USD":533756000.0,"ShareBasedCompensation_3_Q3_USD":17182000.0,"ShareBasedCompensation_1_Q3_USD":6114000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-400225000.0,"RestrictedCashNoncurrent_0_Q3_USD":210000.0,"RestrictedCash_0_Q3_USD":210000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":63765000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":22367000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":7250000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2731000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":3409000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":229469000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5460000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1045000.0,"PaymentsOfDebtExtinguishmentCosts_3_Q3_USD":611000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":561141000.0,"Liabilities_0_Q3_USD":27385000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":705000.0,"CommonStockSharesOutstanding_0_Q3_shares":66504000.0,"CommonStockSharesIssued_0_Q3_shares":66504000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-286310000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":39393000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":39183000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1_0_Q3_security":22.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":504262000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":320900000.0,"AssetsCurrent_0_Q3_USD":548905000.0,"Assets_0_Q3_USD":561141000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6950000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":6950000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":17182000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":6114000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":934168000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-194000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":678000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-3175000.0,"AccountsPayableCurrent_0_Q3_USD":2875000.0,"CommonStockValue_0_Q3_USD":7000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-33167000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-97963000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":572000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2375000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1863000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":929000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2319000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":8058000.0,"InterestAndOtherIncome_3_Q3_USD":911000.0,"InterestAndOtherIncome_1_Q3_USD":311000.0,"InterestAndDebtExpense_3_Q3_USD":414000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1488000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":66353000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":-39000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-2549000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":34455000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11310000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-212000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6436000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.47,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.5,"Depreciation_3_Q3_USD":392000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":200200000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_3_Q3_USD":0.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":746000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":66285000.0,"Ticker":"KURA","CIK":"1422143","name":"KURA ONCOLOGY, INC.","OfficialName":"Kura Oncology Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1071823749.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]